loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 212832 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Fresenius Kabi USA, LLC

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 FRESENIUS KABI USA (3)

    filter

    01 SOLUTION;INTRAVENOUS (3)

    filter

    01 RX (3)

    filter

    01 POTASSIUM PHOSPHATES (3)

    filter

    01 Yes (3)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag Austria
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC

      PDF Supplier PDF
      URL Supplier Web Content
      SOLUTION; INTRAVEN...
      3.54GM/15ML (236MG...
      2019-11-26
      212832
      POTASSIUM PHOSPHAT...
      RX
      Yes
      AP
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content
      Contact Supplier
        Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
        Post an Enquiry Post an Enquiry
        Flag Austria
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC

        PDF Supplier PDF
        URL Supplier Web Content
        SOLUTION; INTRAVEN...
        11.8GM/50ML (236MG...
        2019-11-26
        212832
        POTASSIUM PHOSPHAT...
        RX
        Yes
        AP
        ASK
        US
        PHARMACOMPASS
        Upload
        your Marketing & Sales content
        Contact Supplier
          Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
          Post an Enquiry Post an Enquiry
          Flag Austria
          Virtual Booth Virtual Booth
          Digital Content Digital Content

          POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC

          PDF Supplier PDF
          URL Supplier Web Content
          SOLUTION; INTRAVEN...
          1.18GM/5ML (236MG/...
          2019-11-26
          212832
          POTASSIUM PHOSPHAT...
          RX
          Yes
          AP
          ASK
          US
          PHARMACOMPASS
          Upload
          your Marketing & Sales content

          Looking for FDA Orange Book APPLICATION 212832

          Looking for FDA Orange Book APPLICATION 212832 3

          19

          Fresenius Kabi USA, LLC, based in Austria, is a pharmaceutical company.

          One of their notable products is POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC, with a corresponding application number 212832.

          Regulatory Information RX

          With a dosage strength 3.54GM/15ML (236MG/ML);3.36GM/15ML (224MG/ML)

          Dosage Form Route SOLUTION; INTRAVENOUS

          Reference Listed Drug Yes

          Approved since 2019-11-26

          Therapeutic Equivalence (TE) Code AP

          18

          Fresenius Kabi USA, LLC, based in Austria, is a pharmaceutical company.

          One of their notable products is POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC, with a corresponding application number 212832.

          Regulatory Information RX

          With a dosage strength 11.8GM/50ML (236MG/ML);11.2GM/50ML (224MG/ML)

          Dosage Form Route SOLUTION; INTRAVENOUS

          Reference Listed Drug Yes

          Approved since 2019-11-26

          Therapeutic Equivalence (TE) Code AP

          17

          Fresenius Kabi USA, LLC, based in Austria, is a pharmaceutical company.

          One of their notable products is POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC, with a corresponding application number 212832.

          Regulatory Information RX

          With a dosage strength 1.18GM/5ML (236MG/ML);1.12GM/5ML (224MG/ML)

          Dosage Form Route SOLUTION; INTRAVENOUS

          Reference Listed Drug Yes

          Approved since 2019-11-26

          Therapeutic Equivalence (TE) Code AP

          Post Enquiry
          POST ENQUIRY